XAIR · Beyond Air, Inc. · Financials
Substantial doubt about the company's ability to continue as a going concern.
“Management believes these factors raise substantial doubt about the Company's ability to meet its obligations with cash on hand and concluded that the Company will require additional funding within one year from the date these financial statements are issued. Management is confident that the efforts to arrange financing, while not assured, will enable them to meet the Company's obligations.”View the 10-Q filed Aug 13, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2027 (G) | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $16M – $18M | $7.69M | $7.68MG | $3.71MG | $1.16M | — | — | $873K | $1.39M | $7.72M | — | — | — | |
| — | $378K | $303K | $705K | — | — | — | — | — | — | — | — | — | |
| — | -$11.57M | — | — | — | — | — | — | — | — | — | -$6.98M | — | |
| — | $7.37M | $7.43M | $5.37M | $2.47M | $555K | — | — | — | — | — | — | — | |
| — | $321K | $252K | -$1.66M | -$1.31M | -$555K | — | — | — | — | — | — | — | |
| — | — | 3.28% | -44.89% | -112.77% | — | — | — | — | — | — | — | — | |
| — | $9.11M | $10.24M | $16.86M | $24.36M | $16.81M | $11.8M | $12.62M | $10.65M | $3.93M | $4.64M | $4.44M | — | |
| — | — | — | — | $37.34M | $34.69M | $18.41M | $10.47M | $8.88M | $6.85M | $5.31M | $6.63M | $67.15K | |
| — | $19.25M | $19.06M | $26.02M | $37.34M | — | — | — | — | — | — | — | — | |
| — | $204K | $204K | $205K | $205K | $205K | $38K | — | — | — | — | — | — | |
| — | $3.1M | $3.1M | $3M | $1.8M | $600K | $314K | $173K | $77.17K | $64.79K | — | — | — | |
| — | $28.36M | $29.3M | $42.87M | $61.7M | $51.5M | $40.71M | — | — | — | — | — | $67.15K | |
| — | -$28.04M | -$29.04M | -$44.54M | -$63.01M | -$52.06M | -$40.71M | -$22.21M | -$18.14M | -$3.06M | $9.94M | -$11.07M | -$67.15K | |
| — | — | -378.23% | -1202.08% | -5436.24% | — | — | -2544.56% | -1305.08% | -39.6% | — | — | — | |
| — | -$24.94M | -$25.94M | -$41.54M | -$61.21M | -$51.46M | -$40.4M | -$22.04M | -$18.06M | -$2.99M | — | — | — | |
| — | $4.46M | $3.52M | $3.02M | $2.91M | $30K | $775K | $642K | $30.54K | $1506 | — | — | $895 | |
| — | -$6.37M | -$5.29M | -$3.94M | -$1.29M | -$7.34M | -$3.35M | -$661K | -$1.95M | -$3.5M | -$772.68K | -$6.98M | — | |
| — | -$34.41M | -$34.33M | -$48.48M | -$64.3M | -$59.4M | -$44.06M | -$22.88M | -$20.1M | -$6.59M | — | -$18.04M | — | |
| — | — | — | — | — | — | — | — | -$154.3K | — | — | $27K | — | |
| — | -$33.18M | -$33.25M | -$46.63M | -$60.24M | -$55.82M | -$43.18M | -$22.88M | -$19.94M | -$6.56M | -$10.72M | -$18.04M | -$68.25K | |
| — | — | -432.99% | -1258.43% | -5197.76% | — | — | -2620.27% | -1434.61% | -84.91% | — | — | — | |
| — | -$917K | -$1.09M | -$1.85M | -$4.05M | -$3.59M | -$882K | — | — | — | — | — | — | |
| — | — | — | — | — | — | — | -$22.54M | -$20.46M | -$6.56M | — | -$18.04M | — | |
| — | — | -$33.06M | -$46.67M | — | — | — | — | — | -$6.56M | — | -$18.04M | — | |
| USD/shares | — | -$60.53 | -$80.20 | -$275.40 | -$728.00 | -$744.00 | -$672.00 | -$508.00 | — | -$308.00 | -$1,076.00 | — | — |
| USD/shares | — | -$60.53 | -$80.20 | -$275.40 | -$728.00 | -$744.00 | — | — | — | -$308.00 | -$1,076.00 | — | — |
| shares | — | — | 415.05K | 169.27K | 82.9K | 74.93K | 64.17K | 45.01M | 28.77K | 21.25K | 15.98K | 15.01K | 258 |
| shares | — | — | 415.05K | 169.27K | 82.9K | 74.93K | — | 45.01K | 28.77K | 21.25K | 15.98K | 15.01K | 258 |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2019: $50K in buybacks.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 223,000 | 10-Q filed 2026-08-13 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 977,000 | 10-Q filed 2026-08-13 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 44 similar-size Medical Devices companies (of 150 listed).